Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01148407

Enrollment

Registered

2010-06-22

Start date

2010-06-30

Completion date

2013-08-31

Last updated

2011-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

breast cancer, platelets, metastatic cancer, malignancy

Brief summary

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with a diagnosis of malignancy

Exclusion criteria

* Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Countries

United States

Contacts

Primary ContactChris E Holmes, MD, PhD

ceholmes@uvm.edu802-656-0302

Outcome results